{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:39:29Z","timestamp":1792701569099,"version":"4.5.0"},"reference-count":416,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.pharmthera.2014.02.007","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T04:20:23Z","timestamp":1393388423000},"page":"87-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":153,"title":["Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease"],"prefix":"10.1016","volume":"143","author":[{"given":"Behzad","family":"Yeganeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Wiechec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudharsana R.","family":"Ande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel Rezaei","family":"Moghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren H.","family":"Freed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahla","family":"Shojaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir A.","family":"Zeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Ghavami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2014.02.007_bb0005","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.yexcr.2003.08.006","article-title":"RhoA induces MMP-9 expression at CD44 lamellipodial focal complexes and promotes HMEC-1 cell invasion","volume":"291","author":"Abecassis","year":"2003","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0010","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.4049\/jimmunol.167.8.4609","article-title":"The functional role of rho and rho-associated coiled-coil forming protein kinase in eotaxin signaling of eosinophils","volume":"167","author":"Adachi","year":"2001","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.pharmthera.2014.02.007_bb0015","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.matbio.2013.03.004","article-title":"Type VIII collagen signals via beta1 integrin and RhoA to regulate MMP-2 expression and smooth muscle cell migration","volume":"32","author":"Adiguzel","year":"2013","journal-title":"Matrix Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0020","doi-asserted-by":"crossref","first-page":"6962","DOI":"10.1128\/MCB.18.12.6962","article-title":"p21(WAF1\/CIP1) is upregulated by the geranylgeranyltransferase I inhibitor GGTI-298 through a transforming growth factor beta- and Sp1-responsive element: involvement of the small GTPase rhoA","volume":"18","author":"Adnane","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0025","first-page":"2225","article-title":"Suppression of rho B expression in invasive carcinoma from head and neck cancer patients","volume":"8","author":"Adnane","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0030","first-page":"2223","article-title":"Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells","volume":"5","author":"Agarwal","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1513\/pats.201108-050MS","article-title":"Systemic inflammation and comorbidities in chronic obstructive pulmonary disease","volume":"9","author":"Agusti","year":"2012","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0040","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1165\/rcmb.2010-0041OC","article-title":"Simvastatin improves epithelial dysfunction and airway hyperresponsiveness: from asymmetric dimethyl-arginine to asthma","volume":"44","author":"Ahmad","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0045","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.4049\/jimmunol.178.4.2507","article-title":"Simvastatin potentiates TNF-alpha-induced apoptosis through the down-regulation of NF-kappaB-dependent antiapoptotic gene products: role of IkappaBalpha kinase and TGF-beta-activated kinase-1","volume":"178","author":"Ahn","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0050","doi-asserted-by":"crossref","first-page":"10J","DOI":"10.1016\/0002-9149(88)90002-1","article-title":"Discovery, biochemistry and biology of lovastatin","volume":"62","author":"Alberts","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0060","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1073\/pnas.77.7.3957","article-title":"Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent","volume":"77","author":"Alberts","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0070","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1164\/rccm.200705-656OC","article-title":"Statin use reduces decline in lung function: VA Normative Aging Study","volume":"176","author":"Alexeeff","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0075","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1160\/TH12-05-0337","article-title":"Translating the effects of statins: from redox regulation to suppression of vascular wall inflammation","volume":"108","author":"Antonopoulos","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0080","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00280-010-1300-6","article-title":"Characterization of the in vitro activity of AZD3409, a novel prenyl transferase inhibitor","volume":"67","author":"Appels","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0085","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/MOL.0b013e32833b776c","article-title":"Do structural differences in statins correlate with clinical efficacy?","volume":"21","author":"Arnaboldi","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0090","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1113\/jphysiol.2012.237834","article-title":"Hypoxia-reoxygenation-induced endothelial barrier failure: role of RhoA, Rac1 and myosin light chain kinase","volume":"591","author":"Aslam","year":"2013","journal-title":"J Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0095","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1440-1843.2011.02116.x","article-title":"An epidemiological study of the effects of statin use on airflow limitation in patients with chronic obstructive pulmonary disease","volume":"17","author":"Bando","year":"2012","journal-title":"Respirology"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0100","doi-asserted-by":"crossref","first-page":"e46691","DOI":"10.1371\/journal.pone.0046691","article-title":"Statin use and risk of prostate cancer: a meta-analysis of observational studies","volume":"7","author":"Bansal","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0105","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1164\/rccm.2604008","article-title":"Against the Dutch hypothesis: asthma and chronic obstructive pulmonary disease are distinct diseases","volume":"174","author":"Barnes","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0110","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nri2254","article-title":"Immunology of asthma and chronic obstructive pulmonary disease","volume":"8","author":"Barnes","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0115","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.pupt.2011.06.003","article-title":"Statins and outcome after hospitalization for COPD exacerbation: a prospective study","volume":"24","author":"Bartziokas","year":"2011","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0120","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1183\/09031936.00180812","article-title":"Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD","volume":"41","author":"Beghe","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0125","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1038\/sj.onc.1209682","article-title":"Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma","volume":"25","author":"Bellovin","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0130","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/onc.2012.42","article-title":"Analysis of Rho GTPase expression in T-ALL identifies RhoU as a target for Notch involved in T-ALL cell migration","volume":"32","author":"Bhavsar","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0135","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mvr.2008.09.006","article-title":"Small GTPases in mechanosensitive regulation of endothelial barrier","volume":"77","author":"Birukov","year":"2009","journal-title":"Microvasc Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0140","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mvr.2003.09.007","article-title":"Role of Rho GTPases in thrombin-induced lung vascular endothelial cells barrier dysfunction","volume":"67","author":"Birukova","year":"2004","journal-title":"Microvasc Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0145","doi-asserted-by":"crossref","first-page":"L965","DOI":"10.1152\/ajplung.00292.2011","article-title":"Stimulation of Rho signaling by pathologic mechanical stretch is a \u201csecond hit\u201d to Rho-independent lung injury induced by IL-6","volume":"302","author":"Birukova","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0150","doi-asserted-by":"crossref","first-page":"30611","DOI":"10.1074\/jbc.270.51.30611","article-title":"Novel tricyclic inhibitors of farnesyl protein transferase. Biochemical characterization and inhibition of Ras modification in transfected Cos cells","volume":"270","author":"Bishop","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0155","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/j.1742-1241.2008.01731.x","article-title":"Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study","volume":"62","author":"Blamoun","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/cr.2010.16","article-title":"Slaying RAS with a synthetic lethal weapon","volume":"20","author":"Bommi-Reddy","year":"2010","journal-title":"Cell Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0165","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1200\/JCO.2007.10.8936","article-title":"Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients","volume":"25","author":"Bonovas","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0170","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/eurheartj\/ehi645","article-title":"Is atrial fibrillation an inflammatory disorder?","volume":"27","author":"Boos","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0175","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0962-8924(03)00037-0","article-title":"Bacterial virulence factors targeting Rho GTPases: parasitism or symbiosis?","volume":"13","author":"Boquet","year":"2003","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0180","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1096\/fj.11-192252","article-title":"Off the beaten paths: alternative and crosstalk regulation of Rho GTPases","volume":"26","author":"Boulter","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0185","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/ncb2049","article-title":"Regulation of Rho GTPase crosstalk, degradation and activity by RhoGDI1","volume":"12","author":"Boulter","year":"2010","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0190","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/molbev\/msl145","article-title":"Evolution of the Rho family of ras-like GTPases in eukaryotes","volume":"24","author":"Boureux","year":"2007","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0195","first-page":"2761","article-title":"Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells","volume":"20","author":"Bouterfa","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0200","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ceb.2005.08.012","article-title":"The challenges of abundance: epithelial junctions and small GTPase signalling","volume":"17","author":"Braga","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0205","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2466-11-16","article-title":"Effects of short-term treatment with atorvastatin in smokers with asthma\u2014a randomized controlled trial","volume":"11","author":"Braganza","year":"2011","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0210","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1476-5381.2012.02131.x","article-title":"Selective inhibition by simvastatin of IRF3 phosphorylation and TSLP production in dsRNA-challenged bronchial epithelial cells from COPD donors","volume":"168","author":"Brandelius","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0215","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1674-8301(11)60041-9","article-title":"Competitive metabolism of l-arginine: arginase as a therapeutic target in asthma","volume":"25","author":"Bratt","year":"2011","journal-title":"J Biomed Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0220","doi-asserted-by":"crossref","first-page":"8313","DOI":"10.1073\/pnas.89.17.8313","article-title":"Tetrapeptide inhibitors of protein farnesyltransferase: amino-terminal substitution in phenylalanine-containing tetrapeptides restores farnesylation","volume":"89","author":"Brown","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0225","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/B:BREA.0000018422.02237.f9","article-title":"Altered Rho GTPase signaling pathways in breast cancer cells","volume":"84","author":"Burbelo","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0230","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/carcin\/bgi036","article-title":"Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells","volume":"26","author":"Cafforio","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0235","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.trsl.2009.06.008","article-title":"Targeting the airway smooth muscle for asthma treatment","volume":"154","author":"Camoretti-Mercado","year":"2009","journal-title":"Transl Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0240","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0245","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jacc.2006.04.070","article-title":"Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy","volume":"48","author":"Cannon","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0250","doi-asserted-by":"crossref","first-page":"15902","DOI":"10.1073\/pnas.0807840105","article-title":"A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model","volume":"105","author":"Capell","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.pharmthera.2014.02.007_bb0255","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pupt.2013.06.005","article-title":"Rosuvastatin inhibits human airway smooth muscle cells mitogenic response to eicosanoid contractile agents","volume":"27","author":"Capra","year":"2013","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0260","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1165\/rcmb.2011-0411OC","article-title":"Low-dose fluvastatin reverses the hypoxic pulmonary adventitial fibroblast phenotype in experimental pulmonary hypertension","volume":"47","author":"Carlin","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0265","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1165\/rcmb.2007-0012OC","article-title":"Fluvastatin inhibits hypoxic proliferation and p38 MAPK activity in pulmonary artery fibroblasts","volume":"37","author":"Carlin","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0270","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00280-010-1488-5","article-title":"Phase I and pharmacokinetic study of lonafarnib, Sch 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumors","volume":"67","author":"Castaneda","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0275","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1165\/rcmb.2010-0306OC","article-title":"Protein prenylation contributes to the effects of LPS on EFS-induced responses in human isolated bronchi","volume":"45","author":"Cazzola","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0280","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0962-8924(01)02122-5","article-title":"The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis","volume":"11","author":"Chang","year":"2001","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0300","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.intimp.2010.03.012","article-title":"Simvastatin attenuates acrolein-induced mucin production in rats: involvement of the Ras\/extracellular signal-regulated kinase pathway","volume":"10","author":"Chen","year":"2010","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0285","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejphar.2012.02.015","article-title":"Atorvastatin synergizes with IFN-gamma in treating human non-small cell lung carcinomas via potent inhibition of RhoA activity","volume":"682","author":"Chen","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0295","doi-asserted-by":"crossref","first-page":"L575","DOI":"10.1152\/ajplung.00428.2007","article-title":"Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition","volume":"295","author":"Chen","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0290","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/cvr\/cvn160","article-title":"HMG-CoA reductase inhibitors activate the unfolded protein response and induce cytoprotective GRP78 expression","volume":"80","author":"Chen","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0305","doi-asserted-by":"crossref","first-page":"L705","DOI":"10.1152\/ajplung.00531.2007","article-title":"Lovastatin inhibits bronchial hyperresponsiveness by reducing RhoA signaling in rat allergic asthma","volume":"294","author":"Chiba","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0310","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1165\/rcmb.2008-0162OC","article-title":"Interleukin-13 augments bronchial smooth muscle contractility with an up-regulation of RhoA protein","volume":"40","author":"Chiba","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0315","doi-asserted-by":"crossref","first-page":"L984","DOI":"10.1152\/ajplung.00178.2009","article-title":"Inhibition of geranylgeranyltransferase inhibits bronchial smooth muscle hyperresponsiveness in mice","volume":"297","author":"Chiba","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0320","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1177\/039463200902200408","article-title":"GGTI-2133, an inhibitor of geranylgeranyltransferase, inhibits infiltration of inflammatory cells into airways in mouse experimental asthma","volume":"22","author":"Chiba","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0325","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00011-009-0043-5","article-title":"Lovastatin inhibits antigen-induced airway eosinophilia without affecting the production of inflammatory mediators in mice","volume":"58","author":"Chiba","year":"2009","journal-title":"Inflamm Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0330","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/09687688.2011.603101","article-title":"Regulation of small GTPases at epithelial cell\u2013cell junctions","volume":"28","author":"Citi","year":"2011","journal-title":"Mol Membr Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0335","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/35020106","article-title":"Genomic analysis of metastasis reveals an essential role for RhoC","volume":"406","author":"Clark","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0340","doi-asserted-by":"crossref","first-page":"15051","DOI":"10.1073\/pnas.0910258107","article-title":"Dysregulation of the mevalonate pathway promotes transformation","volume":"107","author":"Clendening","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0345","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1038\/onc.2012.6","article-title":"Targeting tumor cell metabolism with statins","volume":"31","author":"Clendening","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0350","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/thoraxjnl-2012-201634","article-title":"Epithelial eotaxin-2 and eotaxin-3 expression: relation to asthma severity, luminal eosinophilia and age at onset","volume":"67","author":"Coleman","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0355","first-page":"941","article-title":"Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells","volume":"2","author":"Collisson","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0360","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/thx.2010.138990","article-title":"Simvastatin in the treatment of asthma: lack of steroid-sparing effect","volume":"65","author":"Cowan","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0365","doi-asserted-by":"crossref","first-page":"48213","DOI":"10.1074\/jbc.M106473200","article-title":"Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages","volume":"276","author":"Coxon","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0370","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1359\/jbmr.2000.15.8.1467","article-title":"Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298","volume":"15","author":"Coxon","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0375","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00001813-200103000-00001","article-title":"Ras biochemistry and farnesyl transferase inhibitors: a literature survey","volume":"12","author":"Crul","year":"2001","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0380","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1164\/rccm.200605-713OC","article-title":"C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease","volume":"175","author":"Dahl","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2014.02.007_bb0385","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1183\/09031936.00042512","article-title":"Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy","volume":"42","author":"Davis","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0390","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1161\/01.ATV.20.11.e83","article-title":"The transcription factor NF-kappa B and the regulation of vascular cell function","volume":"20","author":"De Martin","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0395","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/hc3001.092039","article-title":"Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor","volume":"104","author":"Dechend","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0400","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nrc1751","article-title":"Statins and cancer prevention","volume":"5","author":"Demierre","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0405","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0898-6568(02)00124-9","article-title":"Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells","volume":"15","author":"Denoyelle","year":"2003","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0410","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/carcin\/22.8.1139","article-title":"Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study","volume":"22","author":"Denoyelle","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0415","doi-asserted-by":"crossref","first-page":"L1134","DOI":"10.1152\/ajplung.00022.2004","article-title":"RhoA and Rac1 are both required for efficient wound closure of airway epithelial cells","volume":"287","author":"Desai","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0420","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1515\/BC.2009.110","article-title":"Specific induction of migration and invasion of pancreatic carcinoma cells by RhoC, which differs from RhoA in its localisation and activity","volume":"390","author":"Dietrich","year":"2009","journal-title":"Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0425","doi-asserted-by":"crossref","first-page":"L992","DOI":"10.1152\/ajplung.00175.2011","article-title":"Rho kinase signaling pathways during stretch in primary alveolar epithelia","volume":"302","author":"DiPaolo","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0430","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2466-9-32","article-title":"Associations between statins and COPD: a systematic review","volume":"9","author":"Dobler","year":"2009","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0435","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0440","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000092077","article-title":"Rhinoviral infections activate p38MAP-kinases via membrane rafts and RhoA","volume":"17","author":"Dumitru","year":"2006","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0445","doi-asserted-by":"crossref","first-page":"33079","DOI":"10.1074\/jbc.M400732200","article-title":"Mevalonate promotes the growth of tumors derived from human cancer cells in vivo and stimulates proliferation in vitro with enhanced cyclin-dependent kinase-2 activity","volume":"279","author":"Duncan","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0450","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/01.RES.81.6.963","article-title":"Mevalonate-dependent inhibition of transendothelial migration and chemotaxis of human peripheral blood neutrophils by pravastatin","volume":"81","author":"Dunzendorfer","year":"1997","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0455","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.pharmthera.2012.12.003","article-title":"Role of Rho-kinase and its inhibitors in pulmonary hypertension","volume":"137","author":"Duong-Quy","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0460","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1183\/09031936.00056610","article-title":"Increased Rho-kinase expression and activity and pulmonary endothelial dysfunction in smokers with normal lung function","volume":"37","author":"Duong-Quy","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0465","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1476-5381.2010.01111.x","article-title":"Protein isoprenylation regulates osteogenic differentiation of mesenchymal stem cells: effect of alendronate, and farnesyl and geranylgeranyl transferase inhibitors","volume":"162","author":"Duque","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0470","first-page":"131","article-title":"Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro","volume":"61","author":"End","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0475","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2183\/pjab.86.484","article-title":"A historical perspective on the discovery of statins","volume":"86","author":"Endo","year":"2010","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0480","doi-asserted-by":"crossref","first-page":"420","DOI":"10.7164\/antibiotics.38.420","article-title":"Monacolins J and L, new inhibitors of cholesterol biosynthesis produced by Monascus ruber","volume":"38","author":"Endo","year":"1985","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0485","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.7164\/antibiotics.29.1346","article-title":"ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium","volume":"29","author":"Endo","year":"1976","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0490","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/eurheartj\/ehi350","article-title":"Inflammation in the genesis and perpetuation of atrial fibrillation","volume":"26","author":"Engelmann","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0495","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1517\/13543781003801076","article-title":"Suppression of farnesyltransferase activity in acute myeloid leukemia and myelodysplastic syndrome: current understanding and recommended use of tipifarnib","volume":"19","author":"Epling-Burnette","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0500","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nature01148","article-title":"Rho GTPases in cell biology","volume":"420","author":"Etienne-Manneville","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0505","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ejso.2004.12.014","article-title":"Correlation between RhoA overexpression and tumour progression in esophageal squamous cell carcinoma","volume":"31","author":"Faried","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0510","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1023\/A:1020355621043","article-title":"Lovastatin alters cytoskeleton organization and inhibits experimental metastasis of mammary carcinoma cells","volume":"19","author":"Farina","year":"2002","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0515","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jacc.2007.09.063","article-title":"Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials","volume":"51","author":"Fauchier","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0520","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/(SICI)1097-0215(19990517)81:4<560::AID-IJC10>3.0.CO;2-7","article-title":"Lovastatin and tumor necrosis factor-alpha exhibit potentiated antitumor effects against Ha-ras-transformed murine tumor via inhibition of tumor-induced angiogenesis","volume":"81","author":"Feleszko","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0525","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ijc.10440","article-title":"Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis-dependent mechanism","volume":"100","author":"Feleszko","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0530","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/1753465807080740","article-title":"Rho kinase as a therapeutic target in the treatment of asthma and chronic obstructive pulmonary disease","volume":"1","author":"Fernandes","year":"2007","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0535","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1465-9921-14-24","article-title":"Three-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease","volume":"14","author":"Ferrari","year":"2013","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0540","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/MCB.16.6.2689","article-title":"Identification of a novel human Rho protein with unusual properties: GTPase deficiency and in vivo farnesylation","volume":"16","author":"Foster","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0545","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0021-9150(03)00299-5","article-title":"Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells","volume":"170","author":"Frick","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0550","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1378\/chest.06-1997","article-title":"Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins","volume":"131","author":"Frost","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0555","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-6147(00)01596-0","article-title":"Rho\u2013Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells","volume":"22","author":"Fukata","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0560","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1006\/bbrc.2001.2008","article-title":"Membrane-bound enzymes of cholesterol synthesis from lanosterol","volume":"292","author":"Gaylor","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0565","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/pr.111.004994","article-title":"Pharmacological actions of statins: a critical appraisal in the management of cancer","volume":"64","author":"Gazzerro","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0570","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.bbamcr.2009.12.005","article-title":"Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c","volume":"1803","author":"Ghavami","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0575","doi-asserted-by":"crossref","first-page":"L420","DOI":"10.1152\/ajplung.00312.2011","article-title":"Geranylgeranyl transferase 1 modulates autophagy and apoptosis in human airway smooth muscle","volume":"302","author":"Ghavami","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0580","doi-asserted-by":"crossref","first-page":"e16523","DOI":"10.1371\/journal.pone.0016523","article-title":"Mevalonate cascade regulation of airway mesenchymal cell autophagy and apoptosis: a dual role for p53","volume":"6","author":"Ghavami","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0585","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1038\/cddis.2012.61","article-title":"Apoptosis, autophagy and ER stress in mevalonate cascade inhibition-induced cell death of human atrial fibroblasts","volume":"3","author":"Ghavami","year":"2012","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0590","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1096\/fj.04-2702fje","article-title":"Simvastatin inhibits T-cell activation by selectively impairing the function of Ras superfamily GTPases","volume":"19","author":"Ghittoni","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0595","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0092-8674(85)90078-9","article-title":"Membrane-bound domain of HMG CoA reductase is required for sterol-enhanced degradation of the enzyme","volume":"41","author":"Gil","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0600","doi-asserted-by":"crossref","first-page":"L1200","DOI":"10.1152\/ajplung.00454.2010","article-title":"Activation of the TLR4 signaling pathway and abnormal cholesterol efflux lead to emphysema in ApoE-deficient mice","volume":"302","author":"Goldklang","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0605","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S0022-2275(20)34418-7","article-title":"Progress in understanding the LDL receptor and HMG-CoA reductase, two membrane proteins that regulate the plasma cholesterol","volume":"25","author":"Goldstein","year":"1984","journal-title":"J Lipid Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0610","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0615","doi-asserted-by":"crossref","first-page":"15575","DOI":"10.1016\/S0021-9258(18)98441-3","article-title":"Nonfarnesylated tetrapeptide inhibitors of protein farnesyltransferase","volume":"266","author":"Goldstein","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0620","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/bies.20238","article-title":"Rho GTPase expression in tumourigenesis: evidence for a significant link","volume":"27","author":"Gomez del Pulgar","year":"2005","journal-title":"Bioessays"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0625","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2012.08.031","article-title":"Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK\/CHOP\/DR5 signaling pathway","volume":"329","author":"Gopalan","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0630","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1248\/bpb.33.710","article-title":"Mechanism of inhibitory effect of prednisolone on RhoA upregulation in human bronchial smooth muscle cells","volume":"33","author":"Goto","year":"2010","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0635","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2141.2005.05481.x","article-title":"Expression of the Rho-family GTPase gene RHOF in lymphocyte subsets and malignant lymphomas","volume":"129","author":"Gouw","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0640","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.pupt.2012.06.002","article-title":"Emerging roles for cholesterol and lipoproteins in lung disease","volume":"26","author":"Gowdy","year":"2013","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0645","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nri1839","article-title":"Statin therapy and autoimmune disease: from protein prenylation to immunomodulation","volume":"6","author":"Greenwood","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0650","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1164\/rccm.200805-691OC","article-title":"RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling","volume":"179","author":"Guilluy","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0655","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1002\/jcp.24005","article-title":"Ox-LDL-induced TGF-beta1 production in human alveolar epithelial cells: involvement of the Ras\/ERK\/PLTP pathway","volume":"227","author":"Guo","year":"2012","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0660","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-1-13","article-title":"Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome","volume":"1","author":"Haas","year":"2006","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0665","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1101\/gad.1310805","article-title":"RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis","volume":"19","author":"Hakem","year":"2005","journal-title":"Genes Dev"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0670","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.biocel.2003.08.007","article-title":"Regulation of tight junctions and loss of barrier function in pathophysiology","volume":"36","author":"Harhaj","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0675","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0955-0674(98)80152-X","article-title":"Therapeutic intervention and signaling","volume":"10","author":"Heimbrook","year":"1998","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0680","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1016\/j.cub.2012.12.008","article-title":"Allergy: airway epithelial Rac1 suppresses allergic inflammation","volume":"23","author":"Henson","year":"2013","journal-title":"Curr Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0685","doi-asserted-by":"crossref","first-page":"397","DOI":"10.5414\/CPP41397","article-title":"Statins differ in their ability to block NF-kappaB activation in human blood monocytes","volume":"41","author":"Hilgendorff","year":"2003","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0690","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1634\/theoncologist.11-3-306","article-title":"The role of statins in cancer therapy","volume":"11","author":"Hindler","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0695","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1073\/pnas.0308525100","article-title":"Rho activity critically and selectively regulates endothelial cell organization during angiogenesis","volume":"101","author":"Hoang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0700","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa032158","article-title":"The nature of small-airway obstruction in chronic obstructive pulmonary disease","volume":"350","author":"Hogg","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0705","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1164\/rccm.201207-1270OC","article-title":"An association between l-arginine\/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype","volume":"187","author":"Holguin","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0710","first-page":"141","article-title":"Synergistic interaction of lovastatin and paclitaxel in human cancer cells","volume":"1","author":"Holstein","year":"2001","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0715","doi-asserted-by":"crossref","first-page":"8648","DOI":"10.1158\/1078-0432.CCR-04-1568","article-title":"3-Hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis","volume":"10","author":"Horiguchi","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0720","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jacc.2003.07.049","article-title":"Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure","volume":"43","author":"Horwich","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0730","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/thx.2008.100198","article-title":"Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma","volume":"63","author":"Hothersall","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0725","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/thx.2005.057976","article-title":"Potential therapeutic role for statins in respiratory disease","volume":"61","author":"Hothersall","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0735","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2362.2010.02434.x","article-title":"Statin use in patients with asthma: a nationwide population-based study","volume":"41","author":"Huang","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0740","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.anai.2012.09.002","article-title":"Effect of oral administration with pravastatin and atorvastatin on airway hyperresponsiveness and allergic reactions in asthmatic mice","volume":"110","author":"Huang","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0745","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/postgradmedj-2011-130209","article-title":"Statin-induced lung injury: diagnostic clue and outcome","volume":"89","author":"Huang","year":"2013","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0750","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0755","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10637-010-9450-2","article-title":"Apoptotic induction by simvastatin in human lung cancer A549 cells via Akt signaling dependent down-regulation of survivin","volume":"29","author":"Hwang","year":"2011","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0760","doi-asserted-by":"crossref","first-page":"E884","DOI":"10.1002\/ijc.27629","article-title":"Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism","volume":"131","author":"Ibrahim","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0765","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.yexcr.2013.02.014","article-title":"25-Hydroxycholesterol promotes fibroblast-mediated tissue remodeling through NF-kappaB dependent pathway","volume":"319","author":"Ichikawa","year":"2013","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0770","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/thx.2007.094540","article-title":"Pravastatin attenuates allergic airway inflammation by suppressing antigen sensitisation, interleukin 17 production and antigen presentation in the lung","volume":"64","author":"Imamura","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0775","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1620\/tjem.212.265","article-title":"Decrease in mortality rate of chronic obstructive pulmonary disease (COPD) with statin use: a population-based analysis in Japan","volume":"212","author":"Ishida","year":"2007","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0780","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1158\/1541-7786.MCR-08-0512","article-title":"RhoC expression and head and neck cancer metastasis","volume":"7","author":"Islam","year":"2009","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0785","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2353\/ajpath.2010.100168","article-title":"Cytoskeletal regulation of epithelial barrier function during inflammation","volume":"177","author":"Ivanov","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0790","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-2249.2012.04564.x","article-title":"Inhibitory effect of statins on inflammatory cytokine production from human bronchial epithelial cells","volume":"168","author":"Iwata","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0795","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1089\/ars.2008.2284","article-title":"Statins in endothelial signaling and activation","volume":"11","author":"Jacobson","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0800","doi-asserted-by":"crossref","first-page":"L1026","DOI":"10.1152\/ajplung.00354.2004","article-title":"Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury","volume":"288","author":"Jacobson","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0805","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1165\/rcmb.2003-0267OC","article-title":"Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin","volume":"30","author":"Jacobson","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0810","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1073\/pnas.88.9.3628","article-title":"Cell cycle-specific effects of lovastatin","volume":"88","author":"Jakobisiak","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0815","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1378\/chest.09-0194","article-title":"Statins in COPD: a systematic review","volume":"136","author":"Janda","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0820","first-page":"483","article-title":"Statins: a new insight into their mechanisms of action and consequent pleiotropic effects","volume":"59","author":"Jasinska","year":"2007","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0825","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.3390\/ijms13078293","article-title":"Fasudil, a rho-kinase inhibitor, attenuates bleomycin-induced pulmonary fibrosis in mice","volume":"13","author":"Jiang","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0830","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2012.07.007","article-title":"The controversies of statin therapy: weighing the evidence","volume":"60","author":"Jukema","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0835","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature11714","article-title":"Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation","volume":"493","author":"Juncadella","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0840","doi-asserted-by":"crossref","first-page":"11","DOI":"10.20452\/pamw.869","article-title":"The influence of simvastatin on selected inflammatory markers in patients with chronic obstructive pulmonary disease","volume":"120","author":"Kaczmarek","year":"2010","journal-title":"Pol Arch Med Wewn"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2014.02.007_bb0845","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000126063","article-title":"HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells","volume":"146","author":"Kagami","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0850","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bbadis.2004.04.006","article-title":"Statin blocks Rho\/Rho-kinase signalling and disrupts the actin cytoskeleton: relationship to enhancement of LPS-mediated nitric oxide synthesis in vascular smooth muscle cells","volume":"1689","author":"Kato","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0855","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1128\/MCB.01029-08","article-title":"Blockade of protein geranylgeranylation inhibits Cdk2-dependent p27Kip1 phosphorylation on Thr187 and accumulates p27Kip1 in the nucleus: implications for breast cancer therapy","volume":"29","author":"Kazi","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0860","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1378\/chest.07-0298","article-title":"The use of statins and lung function in current and former smokers","volume":"132","author":"Keddissi","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0865","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1378\/chest.11-2091","article-title":"Increase of 27-hydroxycholesterol in the airways of patients with COPD: possible role of 27-hydroxycholesterol in tissue fibrosis","volume":"142","author":"Kikuchi","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0875","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1440-1681.2010.05431.x","article-title":"Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis","volume":"37","author":"Kim","year":"2010","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0870","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejphar.2006.11.027","article-title":"Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model","volume":"557","author":"Kim","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0880","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3858\/emm.2009.41.4.031","article-title":"Simvastatin inhibits induction of matrix metalloproteinase-9 in rat alveolar macrophages exposed to cigarette smoke extract","volume":"41","author":"Kim","year":"2009","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0885","doi-asserted-by":"crossref","first-page":"19372","DOI":"10.1073\/pnas.0809966105","article-title":"Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer","volume":"105","author":"Kimmelman","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0890","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.273.5272.245","article-title":"Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)","volume":"273","author":"Kimura","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0895","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1474-4422(05)70150-2","article-title":"Statin therapy in Alzheimer's disease","volume":"4","author":"Kivipelto","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0900","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","article-title":"Rosuvastatin in older patients with systolic heart failure","volume":"357","author":"Kjekshus","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0905","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1465-9921-13-63","article-title":"25-Hydroxycholesterol enhances cytokine release and Toll-like receptor 3 response in airway epithelial cells","volume":"13","author":"Koarai","year":"2012","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0910","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0022-3565(24)37069-7","article-title":"Role of Rho protein in lovastatin-induced breakdown of actin cytoskeleton","volume":"283","author":"Koch","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0915","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0163-7827(02)00002-4","article-title":"Central role of peroxisomes in isoprenoid biosynthesis","volume":"41","author":"Kovacs","year":"2002","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0920","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neulet.2004.08.020","article-title":"Simvastatin induces proliferation inhibition and apoptosis in C6 glioma cells via c-jun N-terminal kinase","volume":"370","author":"Koyuturk","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0925","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.canlet.2006.10.009","article-title":"Simvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signalling through JNK","volume":"250","author":"Koyuturk","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0930","first-page":"1149","article-title":"Cerivastatin demonstrates enhanced antitumor activity against human breast cancer cell lines when used in combination with doxorubicin or cisplatin","volume":"24","author":"Kozar","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0935","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1398-9995.2006.00997.x","article-title":"Effects of various statins on cytokine-dependent growth and IgE-dependent release of histamine in human mast cells","volume":"61","author":"Krauth","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0940","doi-asserted-by":"crossref","first-page":"L604","DOI":"10.1152\/ajplung.00459.2001","article-title":"Mechanisms of NOS2 regulation by Rho GTPase signaling in airway epithelial cells","volume":"283","author":"Kraynack","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0945","doi-asserted-by":"crossref","first-page":"L1286","DOI":"10.1152\/ajplung.00127.2003","article-title":"Statin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells","volume":"285","author":"Kreiselmeier","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0950","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s10495-010-0504-x","article-title":"Impairment of phagocytosis of apoptotic cells and its role in chronic airway diseases","volume":"15","author":"Krysko","year":"2010","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.pharmthera.2014.02.007_bb0955","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/ejcts\/ezt181","article-title":"Preoperative statin therapy in cardiac surgery: a meta-analysis of 90 000 patients","volume":"45","author":"Kuhn","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0960","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1053\/gast.2002.31093","article-title":"3-Hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis","volume":"122","author":"Kusama","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0965","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1023\/A:1025898316728","article-title":"Selective inhibition of cancer cell invasion by a geranylgeranyltransferase-I inhibitor","volume":"20","author":"Kusama","year":"2003","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0970","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.pupt.2012.10.008","article-title":"Statins, systemic inflammation and risk of death in COPD: the Rotterdam study","volume":"26","author":"Lahousse","year":"2013","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0975","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0092-8674(00)81371-9","article-title":"Rac and Cdc42 induce actin polymerization and G1 cell cycle progression independently of p65PAK and the JNK\/SAPK MAP kinase cascade","volume":"87","author":"Lamarche","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0980","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/cr.2013.26","article-title":"Death at the airway epithelium in asthma","volume":"23","author":"Lambrecht","year":"2013","journal-title":"Cell Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0985","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/cbir.1998.0322","article-title":"Lovastatin induces mitotic abnormalities in various cell lines","volume":"23","author":"Lamprecht","year":"1999","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0990","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1183\/09031936.02.00258802","article-title":"Statin-induced fibrotic nonspecific interstitial pneumonia","volume":"19","author":"Lantuejoul","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb0995","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4104\/pcrj.2011.00095","article-title":"Statin use in COPD patients is associated with a reduction in mortality: a national cohort study","volume":"21","author":"Lawes","year":"2012","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1042\/CS20080241","article-title":"Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension","volume":"116","author":"Lee","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1010","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1164\/rccm.200501-041OC","article-title":"Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs","volume":"172","author":"Lee","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1005","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1378\/chest.11-2421","article-title":"Relation between COPD severity and global cardiovascular risk in US adults","volume":"142","author":"Lee","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1020","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.amjcard.2007.09.102","article-title":"Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin","volume":"101","author":"Lee","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1000","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1183\/09031936.00050612","article-title":"Simvastatin suppresses RANTES-mediated neutrophilia in polyinosinic-polycytidylic acid-induced pneumonia","volume":"41","author":"Lee","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1025","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/sj.onc.1201296","article-title":"Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines","volume":"15","author":"Lerner","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0953-6205(02)00011-0","article-title":"Prevention of tumor spread by matrix metalloproteinase-9 inhibition: old drugs, new concept","volume":"13","author":"Lev","year":"2002","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1035","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.leukres.2004.10.007","article-title":"Lovastatin alters the isoprenoid biosynthetic pathway in acute myelogenous leukemia cells in vivo","volume":"29","author":"Lewis","year":"2005","journal-title":"Leuk Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1045","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.ejso.2006.05.012","article-title":"Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma","volume":"32","author":"Li","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejphar.2008.06.082","article-title":"Statins suppress MMP2 secretion via inactivation of RhoA\/ROCK pathway in pulmonary vascular smooth muscles cells","volume":"591","author":"Li","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1050","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1172\/JCI0216421","article-title":"Isoprenoids as mediators of the biological effects of statins","volume":"110","author":"Liao","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1055","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1291\/hypres.31.335","article-title":"Atorvastatin slows the progression of cardiac remodeling in mice with pressure overload and inhibits epidermal growth factor receptor activation","volume":"31","author":"Liao","year":"2008","journal-title":"Hypertens Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1060","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0021-9258(18)89764-2","article-title":"Domain structure of 3-hydroxy-3-methylglutaryl coenzyme A reductase, a glycoprotein of the endoplasmic reticulum","volume":"260","author":"Liscum","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1070","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.lfs.2008.02.012","article-title":"Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK\/STAT pathway","volume":"82","author":"Liu","year":"2008","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1065","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1183\/09031936.06.00025506","article-title":"Regulation of airway smooth muscle RhoA\/ROCK activities by cholinergic and bronchodilator stimuli","volume":"28","author":"Liu","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1075","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001279","article-title":"Do statins improve outcomes in patients with asthma on inhaled corticosteroid therapy? A retrospective cohort analysis","volume":"2","author":"Lokhandwala","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1080","doi-asserted-by":"crossref","first-page":"L1321","DOI":"10.1152\/ajplung.00443.2006","article-title":"Microtubule dynamics and Rac-1 signaling independently regulate barrier function in lung epithelial cells","volume":"293","author":"Lorenowicz","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1085","doi-asserted-by":"crossref","first-page":"L847","DOI":"10.1152\/ajplung.00178.2011","article-title":"Cigarette smoke causes lung vascular barrier dysfunction via oxidative stress-mediated inhibition of RhoA and focal adhesion kinase","volume":"301","author":"Lu","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1090","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/01.ATV.0000068646.76823.AE","article-title":"Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages","volume":"23","author":"Luan","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1095","first-page":"35","article-title":"Regulation of cholesterol synthesis: mechanism for control of HMG CoA reductase","volume":"44","author":"Luskey","year":"1988","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1524-4741.2009.00860.x","article-title":"Over expression of RhoA is associated with progression in invasive breast duct carcinoma","volume":"16","author":"Ma","year":"2010","journal-title":"Breast J"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1105","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature06174","article-title":"Tumour invasion and metastasis initiated by microRNA-10b in breast cancer","volume":"449","author":"Ma","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1110","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1083\/jcb.138.4.927","article-title":"Rho- and rac-dependent assembly of focal adhesion complexes and actin filaments in permeabilized fibroblasts: an essential role for ezrin\/radixin\/moesin proteins","volume":"138","author":"Mackay","year":"1997","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1115","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1378\/chest.06-2838","article-title":"Clarion call for trials assessing \u201ccardiopulmonary\u201d agents to reduce morbidity and mortality in inflammatory lung diseases","volume":"131","author":"Mancini","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1120","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.jacc.2006.04.039","article-title":"Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease","volume":"47","author":"Mancini","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"754\u2013762","key":"10.1016\/j.pharmthera.2014.02.007_bb1125","first-page":"e751","article-title":"Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase","volume":"126","author":"Maneechotesuwan","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1130","first-page":"1763","article-title":"Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells","volume":"10","author":"Manne","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1135","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.4049\/jimmunol.0802280","article-title":"RhoA GTPase activation by TLR2 and TLR3 ligands: connecting via Src to NF-kappa B","volume":"182","author":"Manukyan","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1140","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1517\/17425247.2011.588697","article-title":"Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease management","volume":"8","author":"Marin","year":"2011","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1145","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ejpb.2013.01.021","article-title":"Multiple dosing of simvastatin inhibits airway mucus production of epithelial cells: Implications in the treatment of chronic obstructive airway pathologies","volume":"84","author":"Marin","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/geno.1996.0586","article-title":"Genomic organization and chromosomal location of murine Cdc42","volume":"38","author":"Marks","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1155","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1211\/jpp.57.11.0014","article-title":"Statin-induced apoptosis linked with membrane farnesylated Ras small G protein depletion, rather than geranylated Rho protein","volume":"57","author":"Matzno","year":"2005","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1160","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.bmcl.2008.02.014","article-title":"Synthesis and evaluation of 3- and 7-substituted geranylgeranyl pyrophosphate analogs","volume":"18","author":"Maynor","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1165","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/thoraxjnl-2012-202646","article-title":"Multidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense?","volume":"68","author":"McDonald","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1170","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1158\/1055-9965.EPI-13-0414","article-title":"Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74years of age","volume":"22","author":"McDougall","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1175","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.4049\/jimmunol.172.5.2903","article-title":"A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma","volume":"172","author":"McKay","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1180","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ahj.2007.10.024","article-title":"Effect of statin dose on incidence of atrial fibrillation: data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trials","volume":"155","author":"McLean","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1185","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00018-005-5298-6","article-title":"Isoprenylated proteins","volume":"63","author":"McTaggart","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1190","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1016\/j.rmed.2007.07.018","article-title":"Bronchial airflow limitation, smoking, body mass index, and statin use are strongly associated with the C-reactive protein level in the elderly. The Tromso Study 2001","volume":"101","author":"Melbye","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1195","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.intimp.2013.05.016","article-title":"Redox markers and inflammation are differentially affected by atorvastatin, pravastatin or simvastatin administered before endotoxin-induced acute lung injury","volume":"17","author":"Melo","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1200","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jaci.2006.10.014","article-title":"Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma","volume":"119","author":"Menzies","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1205","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/CRD.0b013e3181f52a7f","article-title":"The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in cardiovascular disease: a comprehensive review","volume":"18","author":"Mihos","year":"2010","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1210","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/153537020422900701","article-title":"Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention","volume":"229","author":"Mo","year":"2004","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1215","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.4049\/jimmunol.171.5.2625","article-title":"Inhibition of Rho family GTPases results in increased TNF-alpha production after lipopolysaccharide exposure","volume":"171","author":"Monick","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1220","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/138920112798868737","article-title":"Statins in the treatment of acute ischemic stroke","volume":"13","author":"Montecucco","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1225","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1164\/rccm.200907-1061OC","article-title":"N-acetylcysteine inhibits RhoA and promotes apoptotic cell clearance during intense lung inflammation","volume":"181","author":"Moon","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1230","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1165\/rcmb.2003-0019OC","article-title":"Rho kinase inhibition initiates apoptosis in human airway epithelial cells","volume":"30","author":"Moore","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1235","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.4049\/jimmunol.176.12.7657","article-title":"Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease","volume":"176","author":"Morimoto","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1240","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1513\/pats.200603-073MS","article-title":"Statins enhance clearance of apoptotic cells through modulation of Rho-GTPases","volume":"3","author":"Morimoto","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1245","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/rccm.200309-1304OC","article-title":"Decreased arginine bioavailability and increased serum arginase activity in asthma","volume":"170","author":"Morris","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1250","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1465-9921-10-45","article-title":"Impact of statins and ACE inhibitors on mortality after COPD exacerbations","volume":"10","author":"Mortensen","year":"2009","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1255","doi-asserted-by":"crossref","first-page":"8354","DOI":"10.4049\/jimmunol.180.12.8354","article-title":"CCL11 and GM-CSF differentially use the Rho GTPase pathway to regulate motility of human eosinophils in a three-dimensional microenvironment","volume":"180","author":"Muessel","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1260","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-pathol-011110-130224","article-title":"Mechanisms of leukocyte transendothelial migration","volume":"6","author":"Muller","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1265","doi-asserted-by":"crossref","first-page":"H1762","DOI":"10.1152\/ajpheart.2000.278.6.H1762","article-title":"Inhibition of Rho protein stimulates iNOS expression in rat vascular smooth muscle cells","volume":"278","author":"Muniyappa","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1270","doi-asserted-by":"crossref","first-page":"L592","DOI":"10.1152\/ajplung.00386.2007","article-title":"Simvastatin attenuates release of neutrophilic and remodeling factors from primary bronchial epithelial cells derived from stable lung transplant recipients","volume":"294","author":"Murphy","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1275","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.freeradbiomed.2013.03.012","article-title":"The role of RhoA and cytoskeleton in myofibroblast transformation in hyperoxic lung fibrosis","volume":"61C","author":"Ni","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1280","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJMoa1201735","article-title":"Statin use and reduced cancer-related mortality","volume":"367","author":"Nielsen","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1285","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/jid.2010.297","article-title":"The farnesyl transferase inhibitor lonafarnib inhibits mTOR signaling and enforces sorafenib-induced apoptosis in melanoma cells","volume":"131","author":"Niessner","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1290","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jama.291.9.1071","article-title":"Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial","volume":"291","author":"Nissen","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1295","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1096\/fj.03-0261fje","article-title":"Lovastatin inhibits Rho-regulated expression of E-selectin by TNFalpha and attenuates tumor cell adhesion","volume":"18","author":"Nubel","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1300","article-title":"Phase I accelerated dose-escalating safety and pharmacokinetic (pk) study of ggti-2418, a novel geranylgeranyltransferase I inhibitor in patients with refractory solid tumors","volume":"21","author":"O'Dwyer","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1305","first-page":"211","article-title":"The development of protein farnesyltransferase inhibitors as signaling-based anticancer agents","volume":"5","author":"Ohkanda","year":"2003","journal-title":"Prog Cell Cycle Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1310","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/bjp.2008.239","article-title":"Therapeutic potential of RhoA\/Rho kinase inhibitors in pulmonary hypertension","volume":"155","author":"Oka","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1315","doi-asserted-by":"crossref","first-page":"32891","DOI":"10.1074\/jbc.M606220200","article-title":"The molecular basis of RhoA specificity in the guanine nucleotide exchange factor PDZ-RhoGEF","volume":"281","author":"Oleksy","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1320","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0092-8674(85)80116-1","article-title":"5\u2032 end of HMG CoA reductase gene contains sequences responsible for cholesterol-mediated inhibition of transcription","volume":"42","author":"Osborne","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1325","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1097\/00029330-200809020-00013","article-title":"Simvastatin attenuates bleomycin-induced pulmonary fibrosis in mice","volume":"121","author":"Ou","year":"2008","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1330","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1440-1843.2009.01549.x","article-title":"Simvastatin attenuates experimental small airway remodelling in rats","volume":"14","author":"Ou","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1335","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1242\/jcs.005306","article-title":"RhoA-mediated apical actin enrichment is required for ciliogenesis and promoted by Foxj1","volume":"120","author":"Pan","year":"2007","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1340","doi-asserted-by":"crossref","first-page":"11044","DOI":"10.1016\/S0021-9258(18)60424-7","article-title":"Sterol-independent regulation of 3-hydroxy-3-methylglutaryl-CoA reductase by mevalonate in Chinese hamster ovary cells. Magnitude and specificity","volume":"264","author":"Panini","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1345","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/01.RES.0000028149.15986.4C","article-title":"3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA","volume":"91","author":"Park","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1350","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.1128\/JVI.73.9.7262-7270.1999","article-title":"RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and facilitates virus-induced syncytium formation","volume":"73","author":"Pastey","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1355","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1021\/jm00015a013","article-title":"Farnesyl diphosphate-based inhibitors of Ras farnesyl protein transferase","volume":"38","author":"Patel","year":"1995","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1360","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0002-9149(00)00910-3","article-title":"Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering","volume":"86","author":"Pedersen","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1365","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.2741\/2401","article-title":"Protein isoprenylation in biology and disease: general overview and perspectives from studies with genetically engineered animals","volume":"12","author":"Perez-Sala","year":"2007","journal-title":"Front Biosci"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1370","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/mi.2009.141","article-title":"Lovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A4","volume":"3","author":"Planaguma","year":"2010","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1375","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1161\/01.CIR.0000065606.63163.B9","article-title":"Simvastatin normalizes autonomic neural control in experimental heart failure","volume":"107","author":"Pliquett","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1380","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ejhg.2010.9","article-title":"The inhibition of mevalonate pathway induces upregulation of NALP3 expression: new insight in the pathogenesis of mevalonate kinase deficiency","volume":"18","author":"Pontillo","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1385","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.bbamem.2009.01.011","article-title":"Multifaceted role of Rho, Rac, Cdc42 and Ras in intercellular junctions, lessons from toxins","volume":"1788","author":"Popoff","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1390","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1395","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","article-title":"A comprehensive survey of Ras mutations in cancer","volume":"72","author":"Prior","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1400","first-page":"2039","article-title":"Down-regulated expression of RhoA in human conventional renal cell carcinoma","volume":"28","author":"Pu","year":"2008","journal-title":"Anticancer Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1405","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.2337\/dc09-0738","article-title":"Statin therapy and risk of developing type 2 diabetes: a meta-analysis","volume":"32","author":"Rajpathak","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1410","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1415","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1038\/sj.onc.1202322","article-title":"Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53","volume":"17","author":"Rao","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1420","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11883-011-0215-y","article-title":"Treatment of familial hypercholesterolemia: is there a need beyond statin therapy?","volume":"14","author":"Raper","year":"2012","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1425","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jcp.1041330320","article-title":"Human bronchial epithelial cells synthesize cholesterol sulfate during squamous differentiation in vitro","volume":"133","author":"Rearick","year":"1987","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1430","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2012.05.018","article-title":"Coronary artery disease is under-diagnosed and under-treated in advanced lung disease","volume":"125","author":"Reed","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1435","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1513\/pats.200410-051SF","article-title":"Clinical approach to patients with chronic obstructive pulmonary disease and cardiovascular disease","volume":"2","author":"Rennard","year":"2005","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1440","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1164\/rccm.200807-1148OC","article-title":"Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoA","volume":"179","author":"Richens","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1445","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1450","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1460","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0962-8924(01)02153-5","article-title":"Rho family proteins: coordinating cell responses","volume":"11","author":"Ridley","year":"2001","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1465","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.tcb.2006.08.006","article-title":"Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking","volume":"16","author":"Ridley","year":"2006","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1470","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1365-2222.2009.03334.x","article-title":"Fluvastatin and lovastatin inhibit granulocyte macrophage-colony stimulating factor-stimulated human eosinophil adhesion to inter-cellular adhesion molecule-1 under flow conditions","volume":"39","author":"Robinson","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1475","first-page":"740973","article-title":"Increased expression of RhoA in epithelium and smooth muscle of obese mouse models: implications for isoprenoid control of airway smooth muscle and fibroblasts","volume":"2013","author":"Ross","year":"2013","journal-title":"J Allergy (Cairo)"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1480","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1200\/JCO.1999.17.11.3631","article-title":"Ras protein farnesyltransferase: a strategic target for anticancer therapeutic development","volume":"17","author":"Rowinsky","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1485","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/thoraxjnl-2012-201823","article-title":"Statins and the risk of interstitial lung disease: a cohort study","volume":"68","author":"Saad","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1490","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1495","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/1091581809333140","article-title":"Effect of atorvastatin on PM10-induced cytokine production by human alveolar macrophages and bronchial epithelial cells","volume":"28","author":"Sakamoto","year":"2009","journal-title":"Int J Toxicol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1500","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/154405910608500608","article-title":"Simvastatin decreases IL-6 and IL-8 production in epithelial cells","volume":"85","author":"Sakoda","year":"2006","journal-title":"J Dent Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1505","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cellimm.2005.08.028","article-title":"Effect of fluvastatin on apoptosis in human CD4+ T cells","volume":"235","author":"Samson","year":"2005","journal-title":"Cell Immunol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1510","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2222.2006.02470.x","article-title":"Inhibitory effects of fluvastatin on cytokine and chemokine production by peripheral blood mononuclear cells in patients with allergic asthma","volume":"36","author":"Samson","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1515","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2332\/allergolint.10-OA-0299","article-title":"Possible Involvement of Sphingosine-1-Phosphate\/G(i)\/RhoA pathways in adherence of eosinophils to pulmonary endothelium","volume":"61","author":"Sashio","year":"2012","journal-title":"Allergol Int"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1520","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/ijc.22328","article-title":"RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line","volume":"120","author":"Sato","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1525","doi-asserted-by":"crossref","first-page":"L946","DOI":"10.1152\/ajplung.00188.2004","article-title":"Role of Rho-kinase in reexpansion pulmonary edema in rabbits","volume":"289","author":"Sawafuji","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1530","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1465-9921-7-121","article-title":"Inhalation of the Rho-kinase inhibitor Y-27632 reverses allergen-induced airway hyperresponsiveness after the early and late asthmatic reaction","volume":"7","author":"Schaafsma","year":"2006","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1535","doi-asserted-by":"crossref","first-page":"L214","DOI":"10.1152\/ajplung.00498.2007","article-title":"The inhaled Rho kinase inhibitor Y-27632 protects against allergen-induced acute bronchoconstriction, airway hyperresponsiveness, and inflammation","volume":"295","author":"Schaafsma","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1540","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1165\/rcmb.2010-0052OC","article-title":"The mevalonate cascade as a target to suppress extracellular matrix synthesis by human airway smooth muscle","volume":"44","author":"Schaafsma","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1545","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejphar.2008.01.056","article-title":"Rho kinase inhibitors: a novel therapeutical intervention in asthma?","volume":"585","author":"Schaafsma","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1550","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.cellsig.2008.04.012","article-title":"Monomeric G-proteins as signal transducers in airway physiology and pathophysiology","volume":"20","author":"Schaafsma","year":"2008","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1555","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vph.2004.05.002","article-title":"Statins prevent oxidized low-density lipoprotein- and lysophosphatidylcholine-induced proliferation of human endothelial cells","volume":"41","author":"Schaefer","year":"2004","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1560","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/apha.12085","article-title":"Effects of simvastatin on pulmonary fibrosis, pulmonary hypertension and exercise capacity in bleomycin-treated rats","volume":"208","author":"Schroll","year":"2013","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1565","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1570","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0163-7258(97)00014-4","article-title":"Inhibition of Ras prenylation: a novel approach to cancer chemotherapy","volume":"74","author":"Sebti","year":"1997","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1575","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1517\/13543784.9.12.2767","article-title":"Farnesyltransferase and geranylgeranyltransferase I inhibitors in cancer therapy: important mechanistic and bench to bedside issues","volume":"9","author":"Sebti","year":"2000","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1580","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2003-37501","article-title":"Statins can inhibit proliferation of human breast cancer cells in vitro","volume":"111","author":"Seeger","year":"2003","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1585","doi-asserted-by":"crossref","first-page":"26277","DOI":"10.1074\/jbc.M111.260562","article-title":"Rho signaling regulates pannexin 1-mediated ATP release from airway epithelia","volume":"286","author":"Seminario-Vidal","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1590","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1595","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.clinthera.2011.12.014","article-title":"Effect of statins on total cholesterol concentrations, cardiovascular morbidity, and all-cause mortality in chronic obstructive pulmonary disease: a population-based cohort study","volume":"34","author":"Sheng","year":"2012","journal-title":"Clin Ther"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1600","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1186\/1471-2458-12-712","article-title":"The comparative effectiveness of statin therapy in selected chronic diseases compared with the remaining population","volume":"12","author":"Sheng","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1605","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1615","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00005-007-0009-7","article-title":"Rho kinase in the regulation of cell death and survival","volume":"55","author":"Shi","year":"2007","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1620","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.4049\/jimmunol.169.4.2134","article-title":"Ras activation in T cells determines the development of antigen-induced airway hyperresponsiveness and eosinophilic inflammation","volume":"169","author":"Shibata","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1625","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1093\/eurheartj\/ehl376","article-title":"T helper 1\/T helper 2 balance and HMG-CoA reductase inhibitors in acute coronary syndrome: statins as immunomodulatory agents?","volume":"27","author":"Shimada","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1630","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3109\/02770903.2012.721433","article-title":"A systematic review of statin efficacy in asthma","volume":"49","author":"Silva","year":"2012","journal-title":"J Asthma"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1635","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00011-012-0579-7","article-title":"Simvastatin abrogates inflamed neutrophil adhesive properties, in association with the inhibition of Mac-1 integrin expression and modulation of Rho kinase activity","volume":"62","author":"Silveira","year":"2013","journal-title":"Inflamm Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1640","doi-asserted-by":"crossref","first-page":"12448","DOI":"10.1016\/S0021-9258(18)37775-5","article-title":"Transcriptional and posttranscriptional regulation of rat hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase by thyroid hormones","volume":"263","author":"Simonet","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1645","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1126\/science.290.5497.1721","article-title":"How cells handle cholesterol","volume":"290","author":"Simons","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1650","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.biophys.32.110601.141803","article-title":"Model systems, lipid rafts, and cell membranes","volume":"33","author":"Simons","year":"2004","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1655","doi-asserted-by":"crossref","first-page":"8694","DOI":"10.1158\/0008-5472.CAN-04-2247","article-title":"Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma","volume":"64","author":"Simpson","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1660","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1161\/01.CIR.0000056767.69054.B3","article-title":"Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease","volume":"107","author":"Sin","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1665","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1093\/annonc\/mdt150","article-title":"Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis","volume":"24","author":"Singh","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1675","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5306\/wjco.v4.i2.43","article-title":"Statin a day keeps cancer at bay","volume":"4","author":"Singh","year":"2013","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1670","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.cgh.2012.12.036","article-title":"Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis","volume":"11","author":"Singh","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1680","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2012.10.005","article-title":"Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis","volume":"144","author":"Singh","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1685","first-page":"393","article-title":"The anticancer properties of statins","volume":"62","author":"Slawinska","year":"2008","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1690","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.tem.2007.12.004","article-title":"Do the cholesterol-lowering properties of statins affect cancer risk?","volume":"19","author":"Solomon","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-4274(92)90167-I","article-title":"Cholesterol and mevalonic acid modulation in cell metabolism and multiplication","volume":"64\u201365","author":"Soma","year":"1992","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1700","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1183\/09031936.00106406","article-title":"Statin use is associated with reduced mortality in COPD","volume":"29","author":"Soyseth","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1705","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3892\/ijo.2011.1273","article-title":"Simvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of BCL-2 gene expression","volume":"40","author":"Spampanato","year":"2012","journal-title":"Int J Oncol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1710","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-2004-869599","article-title":"Anti-inflammatory properties of statins","volume":"4","author":"Steffens","year":"2004","journal-title":"Semin Vasc Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1715","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1161\/CIRCULATIONAHA.110.975284","article-title":"Lapaquistat acetate: development of a squalene synthase inhibitor for the treatment of hypercholesterolemia","volume":"123","author":"Stein","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1720","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.healun.2011.01.720","article-title":"Prevention of transplant coronary artery disease by prenylation inhibitors","volume":"30","author":"Stein","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1725","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1513\/pats.200603-061MS","article-title":"State of the art. Four easy pieces: interconnections between tissue injury, intermediary metabolism, autoimmunity, and chronic degeneration","volume":"3","author":"Steinman","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1730","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/ATVBAHA.107.140673","article-title":"Farnesyltransferase inhibitor, manumycin a, prevents atherosclerosis development and reduces oxidative stress in apolipoprotein E-deficient mice","volume":"27","author":"Sugita","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1735","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1440-1843.2012.02136.x","article-title":"Increased 25-hydroxycholesterol concentrations in the lungs of patients with chronic obstructive pulmonary disease","volume":"17","author":"Sugiura","year":"2012","journal-title":"Respirology"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1740","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000315387","article-title":"Co-morbidity in COPD: the effects of cardiovascular drug therapies","volume":"80","author":"Suissa","year":"2010","journal-title":"Respiration"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1745","first-page":"4919","article-title":"Antitumor efficacy of a novel class of non-thiol-containing peptidomimetic inhibitors of farnesyltransferase and geranylgeranyltransferase I: combination therapy with the cytotoxic agents cisplatin, Taxol, and gemcitabine","volume":"59","author":"Sun","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1750","first-page":"8922","article-title":"Geranylgeranyltransferase I inhibitor GGTI-2154 induces breast carcinoma apoptosis and tumor regression in H-Ras transgenic mice","volume":"63","author":"Sun","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1755","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1074\/jbc.274.11.6930","article-title":"The geranylgeranyltransferase I inhibitor GGTI-298 induces hypophosphorylation of retinoblastoma and partner switching of cyclin-dependent kinase inhibitors. A potential mechanism for GGTI-298 antitumor activity","volume":"274","author":"Sun","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1760","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/156800906775471743","article-title":"Anti-cancer therapy: targeting the mevalonate pathway","volume":"6","author":"Swanson","year":"2006","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1765","doi-asserted-by":"crossref","first-page":"L882","DOI":"10.1152\/ajplung.00238.2007","article-title":"Reversal of elastase-induced pulmonary emphysema and promotion of alveolar epithelial cell proliferation by simvastatin in mice","volume":"294","author":"Takahashi","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1770","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1165\/rcmb.2006-0034OC","article-title":"Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin","volume":"35","author":"Takeda","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1775","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2222.2007.02693.x","article-title":"Effects of Rho-kinase inactivation on eosinophilia and hyper-reactivity in murine airways by allergen challenges","volume":"37","author":"Taki","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1780","doi-asserted-by":"crossref","first-page":"L56","DOI":"10.1152\/ajplung.00159.2010","article-title":"The Rac1\/JNK pathway is critical for EGFR-dependent barrier formation in human airway epithelial cells","volume":"300","author":"Terakado","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1785","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1164\/rccm.201201-0047ED","article-title":"Biological insights from clinical trials and networks","volume":"185","author":"Thannickal","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1790","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1164\/rccm.201206-1113OC","article-title":"Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease","volume":"186","author":"Thomsen","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1795","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00041433-199810000-00002","article-title":"The nuclear factor-kappa B\/inhibitor of kappa B autoregulatory system and atherosclerosis","volume":"9","author":"Thurberg","year":"1998","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1800","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1158\/1078-0432.CCR-12-0489","article-title":"Novel aspects of mevalonate pathway inhibitors as antitumor agents","volume":"18","author":"Thurnher","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1805","article-title":"Statin use in asthmatics on inhaled corticosteroids is associated with decreased risk of emergency department visits","author":"Tse","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1810","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1164\/rccm.201306-1017OC","article-title":"Statin exposure is associated with decreased asthma-related emergency department visits and oral corticosteroid use","volume":"188","author":"Tse","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1815","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bcp.2007.08.031","article-title":"Effects of lovastatin on Rho isoform expression, activity, and association with guanine nucleotide dissociation inhibitors","volume":"75","author":"Turner","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1820","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1006\/bbrc.2000.2315","article-title":"The suppression of small GTPase rho signal transduction pathway inhibits angiogenesis in vitro and in vivo","volume":"269","author":"Uchida","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1825","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1160\/TH09-02-0118","article-title":"Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment","volume":"102","author":"Undas","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1830","doi-asserted-by":"crossref","first-page":"e46303","DOI":"10.1371\/journal.pone.0046303","article-title":"Endothelin-1 augments Na(+)\/H(+) exchange activity in murine pulmonary arterial smooth muscle cells via Rho kinase","volume":"7","author":"Undem","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1835","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/thx.2009.116731","article-title":"COPD and cancer mortality: the influence of statins","volume":"64","author":"van Gestel","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1840","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1242\/dmm.010124","article-title":"Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases","volume":"5","author":"Vance","year":"2012","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1845","first-page":"671","article-title":"The small GTPase RhoA has greater expression in small cell lung carcinoma than in non-small cell lung carcinoma and contributes to their unique morphologies","volume":"22","author":"Varker","year":"2003","journal-title":"Int J Oncol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1850","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0922-4106(95)90143-4","article-title":"Mevalonate pathway and isoprenoids regulate human bronchial myocyte proliferation","volume":"291","author":"Vigano","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1855","doi-asserted-by":"crossref","first-page":"27224","DOI":"10.1074\/jbc.272.43.27224","article-title":"The geranylgeranyltransferase-I inhibitor GGTI-298 arrests human tumor cells in G0\/G1 and induces p21(WAF1\/CIP1\/SDI1) in a p53-independent manner","volume":"272","author":"Vogt","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1860","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1378\/chest.07-0058","article-title":"Systemic inflammation and COPD: the Framingham Heart Study","volume":"133","author":"Walter","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1875","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1177\/0194599811400367","article-title":"Inhibition of inflammatory mediators: role of statins in airway inflammation","volume":"144","author":"Wang","year":"2011","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1865","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1034\/j.1600-0773.2000.d01-16.x","article-title":"Induction of apoptosis by lovastatin through activation of caspase-3 and DNase II in leukaemia HL-60 cells","volume":"86","author":"Wang","year":"2000","journal-title":"Pharmacol Toxicol"},{"issue":"598\u2013606","key":"10.1016\/j.pharmthera.2014.02.007_bb1870","first-page":"e592","article-title":"Statin use and risk of COPD exacerbation requiring hospitalization","volume":"126","author":"Wang","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1880","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/FJC.0b013e3182927e7c","article-title":"HMG-CoA reductase inhibitors, simvastatin and atorvastatin, downregulate ABCG1-mediated cholesterol efflux in human macrophages","volume":"62","author":"Wang","year":"2013","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1885","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1124\/jpet.110.175521","article-title":"Bisphosphonates induce autophagy by depleting geranylgeranyl diphosphate","volume":"337","author":"Wasko","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1890","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1465-9921-7-88","article-title":"RhoA signaling modulates cyclin D1 expression in human lung fibroblasts; implications for idiopathic pulmonary fibrosis","volume":"7","author":"Watts","year":"2006","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1895","doi-asserted-by":"crossref","first-page":"L1323","DOI":"10.1152\/ajplung.00447.2003","article-title":"Connective tissue growth factor expression and induction by transforming growth factor-beta is abrogated by simvastatin via a Rho signaling mechanism","volume":"287","author":"Watts","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1900","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/hc0602.103393","article-title":"Statins have biphasic effects on angiogenesis","volume":"105","author":"Weis","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1905","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/10623320303360","article-title":"Lymphocyte function-associated antigen-1 blockade by statins: molecular basis and biological relevance","volume":"10","author":"Weitz-Schmidt","year":"2003","journal-title":"Endothelium"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1910","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/89058","article-title":"Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site","volume":"7","author":"Weitz-Schmidt","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1915","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/cm.20095","article-title":"Rho family GTPases are activated during HGF-stimulated prostate cancer-cell scattering","volume":"62","author":"Wells","year":"2005","journal-title":"Cell Motil Cytoskeleton"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1920","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00109-002-0370-2","article-title":"Rho\/Rho-kinase mediated signaling in physiology and pathophysiology","volume":"80","author":"Wettschureck","year":"2002","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1925","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.yexcr.2004.08.012","article-title":"Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility","volume":"301","author":"Wheeler","year":"2004","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1930","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1185\/03007990152005388","article-title":"Synthetic statins: more data on newer lipid-lowering agents","volume":"17","author":"Wierzbicki","year":"2001","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1935","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.etp.2008.03.002","article-title":"Rho-kinase and contractile apparatus proteins in murine airway hyperresponsiveness","volume":"60","author":"Witzenrath","year":"2008","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1945","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.leu.2402476","article-title":"HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis","volume":"16","author":"Wong","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1940","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/j.gastro.2010.10.006","article-title":"The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2","volume":"140","author":"Wong","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1950","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1164\/rccm.201003-0399OC","article-title":"Statin reverses smoke-induced pulmonary hypertension and prevents emphysema but not airway remodeling","volume":"183","author":"Wright","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1955","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1465-9921-6-27","article-title":"Atorvastatin reduces lipopolysaccharide-induced expression of cyclooxygenase-2 in human pulmonary epithelial cells","volume":"6","author":"Wu","year":"2005","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1960","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1007\/s00018-012-1044-z","article-title":"Knowledge translation: airway epithelial cell migration and respiratory diseases","volume":"69","author":"Xiao","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1965","doi-asserted-by":"crossref","first-page":"e59233","DOI":"10.1371\/journal.pone.0059233","article-title":"Inhibition of Rho and Rac geranylgeranylation by atorvastatin is critical for preservation of endothelial junction integrity","volume":"8","author":"Xiao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1970","first-page":"753","article-title":"Atorvastatin reduces lipopolysaccharide-induced expression of C-reactive protein in human lung epithelial cells","volume":"4","author":"Xing","year":"2011","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1980","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.intimp.2012.01.012","article-title":"Simvastatin delivery via inhalation attenuates airway inflammation in a murine model of asthma","volume":"12","author":"Xu","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1975","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1164\/rccm.201108-1574OC","article-title":"Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation","volume":"185","author":"Xu","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1985","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2006.02.024","article-title":"Involvement of Rho signaling in PAR2-mediated regulation of neutrophil adhesion to lung epithelial cells","volume":"536","author":"Yagi","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1990","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1073\/pnas.96.3.1024","article-title":"T cell antigen receptor-mediated activation of the Ras\/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation","volume":"96","author":"Yamashita","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb1995","first-page":"3569","article-title":"Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype","volume":"55","author":"Yan","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb2000","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1161\/01.RES.0000268411.49545.9c","article-title":"Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1\/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages","volume":"100","author":"Yano","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb2005","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/BF02256124","article-title":"Enhancing effect of dietary cholesterol and inhibitory effect of pravastatin on allergic pulmonary inflammation","volume":"11","author":"Yeh","year":"2004","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb2010","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1189\/jlb.0205064","article-title":"Differential effects of statins on relevant functions of human monocyte-derived dendritic cells","volume":"79","author":"Yilmaz","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb2015","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1183\/09059180.00005309","article-title":"Pharmacological actions of statins: potential utility in COPD","volume":"18","author":"Young","year":"2009","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb2020","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/pgmj.2008.078477","article-title":"Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence","volume":"85","author":"Young","year":"2009","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb2025","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1465-9921-13-108","article-title":"Statins as potential therapeutic drug for asthma?","volume":"13","author":"Yuan","year":"2012","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb2030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0167-4889(87)90138-8","article-title":"Regulation of hepatic HMG-CoA reductase in vivo by reversible phosphorylation","volume":"927","author":"Zammit","year":"1987","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb2035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.trsl.2010.09.003","article-title":"Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: a novel treatment for airway remodeling?","volume":"156","author":"Zeki","year":"2010","journal-title":"Transl Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb2040","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1164\/rccm.200901-0018OC","article-title":"Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond","volume":"180","author":"Zeki","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb2045","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/187231211794455217","article-title":"Statin drugs, metabolic pathways, and asthma: a therapeutic opportunity needing further research","volume":"5","author":"Zeki","year":"2011","journal-title":"Drug Metab Lett"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb2050","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003314","article-title":"Statin use and asthma control in patients with severe asthma","volume":"3","author":"Zeki","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb2055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1465-9921-13-38","article-title":"Differential effects of simvastatin on IL-13-induced cytokine gene expression in primary mouse tracheal epithelial cells","volume":"13","author":"Zeki","year":"2012","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb2075","doi-asserted-by":"crossref","first-page":"C298","DOI":"10.1152\/ajpcell.00118.2010","article-title":"The effects of the small GTPase RhoA on the muscarinic contraction of airway smooth muscle result from its role in regulating actin polymerization","volume":"299","author":"Zhang","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb2070","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.ajpath.2013.02.008","article-title":"Rac1 and Cdc42 differentially modulate cigarette smoke-induced airway cell migration through p120-catenin-dependent and -independent pathways","volume":"182","author":"Zhang","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb2065","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.biocel.2012.11.001","article-title":"Statins, autophagy and cancer metastasis","volume":"45","author":"Zhang","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb2060","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1245\/s10434-007-9457-x","article-title":"Overexpression of RhoE has a prognostic value in non-small cell lung cancer","volume":"14","author":"Zhang","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb2080","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.ajpath.2012.02.016","article-title":"Protein kinase G-I deficiency induces pulmonary hypertension through Rho A\/Rho kinase activation","volume":"180","author":"Zhao","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb2090","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2174\/138161209787315684","article-title":"Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy","volume":"15","author":"Zhou","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb2095","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1253\/circj.CJ-10-0110","article-title":"Pleiotropic effects of statins. Basic research and clinical perspectives","volume":"74","author":"Zhou","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb2085","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/ijc.25445","article-title":"A distinct role of RhoB in gastric cancer suppression","volume":"128","author":"Zhou","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pharmthera.2014.02.007_bb2100","first-page":"1457","article-title":"Rosuvastatin attenuates mucus secretion in a murine model of chronic asthma by inhibiting the gamma-aminobutyric acid type A receptor","volume":"125","author":"Zhu","year":"2012","journal-title":"Chin Med J (Engl)"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725814000461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725814000461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T22:56:37Z","timestamp":1746140197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725814000461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":416,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0163725814000461"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2014.02.007","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2014.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}